Abstract
Linear IgA disease (LAD) is a group of heterogeneous autoimmune subepidermal bullous diseases characterized by exclusively IgA autoantibodies targeting a component of the epidermal basement membrane zone. The lamina lucida-type LAD, also known as chronic bullous dermatosis of childhood, is a rare disease yet the most common autoimmune bullous disease among children with a peak incidence at 4–5 years of age. The major target antigens in lamina lucida-type LAD are 120 kDa LAD-1 antigen and its carboxyterminal proteolysed form 97 kDa LAD antigen 1 (LABD97). Both proteins are produced by cleavage of the extracellular domain of BP180, one of the main structural components of the hemidesmosome. The autoantigen targeted by IgA in the sublamina densa-type LAD, also known as IgA epidermolysis bullosa acquisita, is type VII collagen. In adults, LAD may also be drug induced.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kasperkiewicz M, Zillikens D, Schmidt E. Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity. 2012;45:55–70.
Lings K, Bygum A. Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark. Acta Derm Venereol. 2015;95:466-71.
Jablonska S, Chorzelski TP, Rosinska D, Maciejowska E. Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol. 1991;9:393–401.
Zone JJ, Egan CA, Taylor TB, Meyer LJ. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc. 2004;9:47–51.
Egan CA, Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 1999;38:818–27.
Chanal J, Ingen-Housz-Oro S, Ortonne N, Duong TA, Thomas M, Valeyrie-Allanore L, Lebrun-Vignes B, André C, Roujeau JC, Chosidow O, Wolkenstein P. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol. 2013;169:1041–8.
Wojnarowska F, Bhogal BS, Black MM. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases. Br J Dermatol. 1994;131:201–4.
Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 1994;30:187–92.
Kasperkiewicz M, Schmidt E. Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol. 2009;6:270–80.
Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol. 2001;19:719–27.
On the Web
DermNet NZ: http://www.dermnetnz.org/immune/linear-iga.html.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Horváth, B., Jonkman, M.F. (2016). Linear IgA Disease. In: Jonkman, M. (eds) Autoimmune Bullous Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-23754-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-23754-1_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23753-4
Online ISBN: 978-3-319-23754-1
eBook Packages: MedicineMedicine (R0)